Introduction
============

Diabetes was recently recognized to induce microvascular complications affecting the renal, visual, and peripheral nervous systems \[[@B1][@B2]\]. The clinical manifestation of diabetes mellitus is characterized by vascular and neuropathic complications \[[@B3][@B4]\]. In the inner ear, angiopathy may occur both directly-by interfering with cochlear blood supply and reducing nutrient transportation-and indirectly-by reducing blood flow due to narrowed vasculature-causing secondary degeneration of the eighth cranial nerve \[[@B5]\].

Although many studies have reported an association between diabetes and hearing loss, these reports have had some limitations; the use of data from animal studies, few subjects, or a cross-sectional study design \[[@B6][@B7]\]. Most studies have reported only an abstractive correlation between common hearing loss and the incidence of diabetes. Thus, there is a need for further research with experimental conditions that control for other variables beyond diabetes, such as noise-induced hearing loss. Accordingly, we conducted our present study to evaluate the impact of diabetes on the occurrence of and recovery from noise-induced hearing loss. We compared the sensitivity and the recovery for noise-induced hearing loss between normal and diabetic mice.

Subjects and Methods
====================

Experimental animals
--------------------

We used 5-week-old male mice with a normal Preyer\'s reflex and normal hearing threshold; C57BLKS/J-m wild type (+/+) mice were used as the control group (11 mice) while C57BLKS/J-db/db mice were used as the diabetic group (13 mice). The mice were allowed to adapt to the laboratory environment for 1 week before the experiment. The animals were housed in silent cages at a temperature of 24±1℃ temperature and maintained in environmentally controlled rooms with a 12-h light/dark cycle, with food and water available ad libitum.

Zolazepam/tiletamine (Zoletil; Virbac, Carros, France) 25 mg/kg and xylazine (Rompun; Bayer, Seoul, Korea) 10 mg/kg were administered intraperitoneally for anesthesia, and half of the above amounts were additionially added if necessary. All animal experiments were performed with the approval of the Animal Care Committee of the University of Ulsan College of Medicine.

Experimental protocol
---------------------

### Resting hearing threshold with aging

Mice were divided into a control group (8 mice) and a diabetic group (9 mice). The hearing levels of each mouse, none of whom was exposed to white noise were evaluated weekly for 7 weeks.

### Hearing threshold changes after noise exposure

The remaining animals were divided into two groups, a control group (3 mice) and a diabetic group (4 mice). Both control and diabetic groups were exposed to broad band white noise of 110 dB SPL (sound pressure level) in a soundproof booth for 3 hours. White noise (0.3-10 kHz) was generated by a personal computer and amplifier (R-399; Interm, Seoul, Korea) and delivered through a speaker (290-8L; Altec Lansing, Oklahoma City, OK, USA) in a noise booth. The amplifier with the speaker on top was placed in the left corner of the noise booth, and the horn was attached at a 45-degree angle. The hearing levels of each mouse were analyzed before and immediately after noise exposure and at following periods; 1, 3, 5, and 7 days, and 2, 3, and 4 weeks after exposure.

Hearing measurements
--------------------

For the measurement of hearing levels, we analyzed the auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) results with an auditory evoked potential workstation (Tucker-Davis Technologies, Alachua, FL, USA). Tone-burst stimulation was used to measure frequency-specific ABRs. The frequencies measured were 4, 8, 16, and 32 kHz, and we gained the waveform by repeatedly decreasing the stimulation tone by 10 dB from a strength of 90 dB SPL. The most uniformly generated waveform was used for analysis. We judged a waveform with an amplitude greater than 0.2 µV that appeared to be similar to the response to the previous stimulation tone to be a significant waveform. DPOAE was measured using an amplifier system that could provide two stimulation tones. We generated f1 and f2 primary stimulation tones (f2/f1=1.2) using a dual channel synthesizer. For the measurement of frequency-specific responses, we set the f2 stimulation tone to 4, 8, 11.3, 16, 22.6, and 32 kHz. The threshold was determined when the DPOAE response exceeded the noise level on the measured graph at each frequency.

Statistical analysis
--------------------

The hearing thresholds of the control and diabetic groups were compared using the Mann-Whitney U test. To evaluate the effects of diabetic on recovery from noise-induced hearing loss, we calculated the rate of hearing level recovery each week. The recovery rate for each week was obtained as follows:

Recovery rate=(recovered hearing threshold/deteriorated hearing threshold)×100%

where the recovered hearing threshold is the difference in the hearing threshold immediately after noise exposure and at each week and the deteriorated hearing threshold is the difference in the hearing threshold before and immediately after noise exposure.

The hearing recovery rates of the two groups were statistically validated with the Mann-Whitney U test. Values of *p*\<0.05 were considered significant. Hearing thresholds are shown as the mean±SD. All statistical analyses were performed using SPSS version 21.0 (IBM, Armonk, NY, USA).

Results
=======

Changes in resting hearing thresholds with aging
------------------------------------------------

The hearing levels of the control group were better than those of diabetic group from 1 to 7 weeks at all ABR frequencies (4, 8, 16, and 32 kHz). The average ABR thresholds at 1 week at 4, 8, 16, and 32 kHz were 44±5 dB SPL, 33±8 dB SPL, 54±5 dB SPL, and 57±9 dB SPL, respectively, in the diabetic mice and 36±4 dB SPL, 26±8 dB SPL, 36±4 dB SPL, and 34±5 dB SPL, respectively, in the control group. The ABR thresholds of the diabetic group were significantly poorer than those of the control group at all frequencies at 1, 2, and 3 weeks, and the DPOAE thresholds of the diabetic group were significantly worse than those of the control group at 8, 11.3, and 16 kHz at 4 and 5 weeks ([Table 1](#T1){ref-type="table"}[Fig. 1](#F1){ref-type="fig"}).

Hearing thresholds changes after noise exposure
-----------------------------------------------

Both the diabetic and control groups showed an increase in the hearing threshold immediately after noise exposure, which began to slowly recover at all frequencies. Although it did not recover to the resting hearing level in either group, the diabetic group showed a higher ABR threshold at all ABR frequencies (4, 8, 16, and 32 kHz) at 4 weeks after noise exposure, and a higher DPOAE threshold at 8 kHz at 1 week and 2, 3, and 4 weeks, compared with the control group ([Table 2](#T2){ref-type="table"}[Fig. 2](#F2){ref-type="fig"}). In order to compensate for the different resting hearing levels before the noise exposure in the two groups, the recovery rates of elevated hearing thresholds after noise exposure were analyzed each week. There were no statistically significant differences in the rate of hearing recovery between the two groups ([Table 3](#T3){ref-type="table"}).

Discussion
==========

Many studies have reported an association between diabetes and hearing loss \[[@B6][@B7][@B8][@B9][@B10][@B11][@B12]\]. Kakarlapudi, et al. \[[@B13]\] reported that sensorineural hearing loss was more common in diabetic patients and that the severity of the hearing loss appeared to correlate with disease progression. A previous animal study reported that diabetic rats had impaired recovery from noise-induced temporary hearing loss \[[@B14]\]. McQueen, et al. \[[@B15]\], however, found that diabetes mellitus alone did not cause significant capillary changes in the cochlea of a genetic diabetic rats models; the changes were observed only in combination with noise exposure or obesity. Several studies have also reported the possible pathogenesis of diabetes-associated hearing loss \[[@B8][@B16]\]. These reports suggested that this pathogenesis includes cochlear microangiopathy, hyperglycemia of the cerebrospinal fluid or perilymph, auditory neuropathy, diabetic encephalopathy, thickened vessels of the stria vascularis, atrophy of the stria vascularis and loss of outer hair cells.

In our present study in the mouse, the resting hearing levels were significantly worse in the diabetic group than in the normal group. After noise exposure, the hearing thresholds were increased in both the control and diabetic groups, but the changes of the hearing thresholds after exposure were not significantly different between the groups. In contrast to previous studies using diabetic rat model \[[@B14][@B17]\], the recovery rates of deteriorated hearing thresholds after noise exposure were similar in our diabetic and control mice, suggesting that diabetes had no significant effect on hearing recovery from noise-induced hearing loss. In clinical studies, Ishii, et al. \[[@B18]\] have reported that patients with diabetes are more prone to the development of severe noise-induced hearing loss and Agrawal, et al. \[[@B19]\] also observed significant interactions between firearm noise exposure and hearing loss in diabetic patients at 3 kHz. Previous studies that reported adverse effects of diabetes on noise-induced hearing loss suggested that disrupted microcirculation in diabetic cochlea may cause loss of spiral ganglion cells and irreversible hearing impairment\[[@B14][@B17]\].

This study had some limitations. First, in our present study with mice, noise-induced hearing impairment was not recovered to the resting hearing level in either the diabetic or control groups. It must be noted that because of the residual hearing impairment at 4 weeks after noise exposure, delayed or limited recovery of diabetic mice may have been missed. We suggested this is the reason why our study showed recovery from noise-induced hearing loss was not affected by diabetes contrary to the previous studies. Therefore, further long-term follow ups of the hearing levels in diabetic mice are needed. Seconds, histopathological studies are needed to assess physiological and morphological alterations in the cochleae over time in mice with or without diabetes.

Conclusion
==========

The hearing level with aging is significantly impaired earlier in diabetic compared with normal mice. After noise exposure, however, the hearing recovery was similar between these groups of mice up to the 4-week follow-up. Further long-term studies of the hearing levels in diabetic mice are needed.
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###### DPOAE thresholds in the control and diabetic mice with aging
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The results are reported as the mean±SD. ^\*^Mann-Whitney U test (*p*-value for the hearing threshold of the control and diabetic groups), ^†^significant results (*p*\<0.05). DM: diabetes mellitus group, Control: control group, DPOAE: distortion product otoacoustic emission

###### DPOAE thresholds in the control and diabetic mice before and after exposure to noise
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The results are reported as the mean±SD. ^\*^Mann-Whitney U test (*p*-value for the hearing threshold of the control and diabetic groups), ^†^significant results (*p*\<0.05). DM: diabetes mellitus group, Control: control group, DPOAE: distortion product otoacoustic emission

###### Recovery rates of hearing threshold after noise exposure in the control and diabetic mice
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The results are reported as the mean ± SD. ^\*^Mann-Whitney U test (*p*-value for the recovery rate of the control and diabetic groups). DM: diabetes mellitus group, Control: control group
